Mohammad Fereidouni
Biographic Data
| ID | 7799000 |
|---|---|
| NAME | Mohammad Fereidouni |
| GIVEN NAMES | Mohammad |
| FAMILY NAME | Fereidouni |
| SIGNATURE | FEREIDOUNI M |
| AFFILIATIONS | Birjand University of Medical Sciences |
| ORCID | 0000-0002-2576-9452 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Safety of sinopharm Covid-19 vaccine in children and adolescents aged 5 to 18 years
Sinopharm is a safe and well-tolerated vaccine option for children and adolescents and can be recommended for this population
No prominent works on this page.
Safety of sinopharm Covid-19 vaccine in children and adolescents aged 5 to 18 years
Sinopharm is a safe and well-tolerated vaccine option for children and adolescents and can be recommended for this population
Biostatistics (1 work) · Cohort (1 work) · Cohort study (1 work) · Epidemiology (1 work) · Intramuscular injections and effects (1 work) · Public health (1 work) · SARS-CoV-2 and COVID-19 Research (1 work) · Vaccine Coverage and Hesitancy (1 work) · Vaccine safety (1 work)